Conference Update From IAS 2011: Prevention
Once again, prevention -- not treatment -- dominated an HIV conference. The latest in the string of prevention bonanzas over the past year: two separate research teams reported that the use of HIV drugs when taken by uninfected people greatly reduced the risk of getting HIV through heterosexual sex.
First, before the conference, the University of Washington released findings from its Partners PrEP ("PrEP" stands for pre-exposure prophylaxis or prevention) study conducted in Kenya and Uganda. Because its interim data clearly showed a benefit to using HIV medications to prevent transmission, the study's independent Data Safety and Monitoring Board (DSMB) recommended that the placebo (fake pill) part of the trial be stopped. Instead, the study participants who had been given a placebo would now be offered one of the two medications being studied for prevention,View Full Article
Visit Positively Aware's website to find out more about the publication.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)